What factors influence measles, mumps and rubella vaccine hesitancy among parents? A systematic review
The United Kingdom lost its measles free status in 2019 because of an increase in measles cases, resulting from lowered vaccination uptake.
This review aims to gather a deeper understanding about parents' health choices for their children related to this vaccination.
A systematic review was carried out with a literature search using CINHAL, MEDLINE and OVID databases to identify information published between September 2016 and February 2020. A critical appraisal of seven studies was completed and a mixed methods synthesis was used to explore the results.
The review identified factors that contribute to a parent's decision to vaccinate their child against measles, mumps and rubella. Five themes emerged: parental knowledge, attitudes and beliefs; safety concerns; specific groups related to religion and natural lifestyles; socioeconomic factors; and the source of health information.
Ongoing health promotion is required for the UK to work towards regaining its measles free status.
Measles, mumps and rubella (MMR) are infectious diseases that can lead to severe complications including disability or death (Demicheli et al, 2012). Measles in particular is a highly contagious viral disease affecting both children and adults (Public Health England (PHE), 2019a) with unvaccinated children under the age of 5 years being most at risk of harm because of their vulnerability (World Health Organization (WHO), 2020).
Prior to the introduction of the MMR vaccine in 1988 (PHE, 2019b), major outbreaks of measles were seen every few years, resulting in millions of deaths each year (WHO, 2020). Since the vaccine's introduction, death rates have declined; however, in 2018, measles surveillance saw a rising trend of cases across Europe and led to the UK losing its ‘measles free status’ in 2019 (WHO, 2019). According to Demicheli et al (2012), fatalities are more commonly seen in countries with higher levels of deprivation and less advanced healthcare systems; however, the risk remains in any country, regardless of wealth. MMR, like many other infectious diseases, are preventable with vaccination, a cost-effective method of protecting the public and preventing ill health. The childhood immunisation schedule recommends two doses of the MMR vaccine: the first at 12 months old and the second at 3–5 years old, to ensure that those with a poor response to the first vaccine achieve an adequate level of protection (PHE, 2019a; b). The current MMR vaccination uptake for first vaccines in under 5-year-olds is high at 94.5%; however, uptake of second doses has fallen to 86.8% and the negative effect of social media has been linked to non-acceptance of this vaccination (Nuffield Trust, 2021).
Register now to continue reading
Thank you for visiting Journal of Child Health and reading some of our peer-reviewed resources for children’s health professionals. To read more, please register today. You’ll enjoy the following great benefits:
Limited access to our clinical or professional articles
New content and clinical newsletter updates each month